Compare ARK Genomic Revolution ETF (ARKG) vs Chubb Ltd (CB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Chubb Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.88, while Chubb Ltd trades at $352.87 (market cap $134.91B). The key difference: Chubb Ltd pays a 1.17% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | CB | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $361.17 |
52-Week Low | $23.09 | $265.99 |
Market Cap | — | $134.91B |
Enterprise Value | — | $155.96B |
Dividend Yield | — | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Chubb Limited (CB) trades at $347.83, showing minimal daily movement with a slight 0.01% gain. The stock exhibits bullish technical signals from moving averages and strong fundamental health, including consistent earnings beats and a net income margin of 18.46%. Recent news highlights disciplined capital deployment and premium growth, while the upcoming Q2 2026 earnings report on July 22, 2026, is highly anticipated.
The outlook remains positive given analyst consensus favoring Buy ratings and a price target of $354.69, suggesting modest upside. Key risks include catastrophe losses and softer commercial pricing, but the company's robust balance sheet and rising investment income support long-term growth potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Chubb Ltd
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Read more on CB →
